Stock Market

Generally, I try to avoid becoming overly negative on a particular company. Based on Murphy’s law, such negativity results in the target firm becoming one of the top-performing hypergrowth securities. But regarding Canoo (NASDAQ:GOEV), I have doubts. From where I stand, everything that could go wrong for the company, did go wrong. Logically, this bodes

There is a bull case for AMC Entertainment (NYSE:AMC) stock. To be clear, I don’t subscribe to that case. But as with nearly every stock out there, a reasonable investor can make a case for being long. Source: QualityHD / Shutterstock.com The end of the novel coronavirus pandemic should boost the company’s revenue after an

There may come a time when the once-hyped real estate loan originator UWM Holdings (NYSE:UWMC) will have its day in the sun again. Until then, we’ll have to wrap our heads around the surprisingly low price of UWMC stock. Source: Shutterstock For six years running, UWM Holdings has been (according to the company, at least) America’s

Gold and silver miners in North America will start reporting their first-quarter earnings reports the week of April 26. Gold stocks have been tracking the gold price, which means the economic recovery has weighed on their performance. Source: allstars / Shutterstock.com In a recent note, RBC Capital Markets analyst Josh Wolfson and his team outlined what

Chamath Palihapitiya is riding high these days. Wall Street’s biggest exponent of special-purpose acquisitions companies, or SPACs, is hoping to create as much wealth as Warren Buffett. He has a pretty good track record thus far. However, the one chink in his armor is Clover Health Investments (NASDAQ:CLOV). CLOV stock is down 36% in the last

The times are changing in the marijuana industry. Three years ago, traders were excited for the Canadian cannabis stocks. That country was about to open up its retail marijuana market and it seemed like the possibilities were endless. Fast-forward to now, however, and the Canadian pot companies have crashed and burned while American players have

Since last November, it’s been investor perception rather than fundamentals driving price action in Palantir (NYSE:PLTR) stock. Trying to value this big data company’s shares using traditional valuation metrics has thus far been a fool’s errand. Source: Sundry Photography / Shutterstock.com You can say the stock’s rich valuation is built on its impressive growth projections.

The SPAC (special purpose acquisition company) craze of 2020 and 2021 may go down in the history books as one of the most speculative market situations in stock market history. 2021 has seen $166 billion in SPAC-led deals so far, more than double 2020’s SPACs issuance of $73 billion. There have been winners and losers

Riot Blockchain (NASDAQ:RIOT) announced on April 12 its first quarter mining production numbers. In addition, the company provided its ultimate Bitcoin (CCC:BTC-USD) production estimates based on its expected mining hash rate over the next year and a half or so to the end of 2022. As a result, it looks like RIOT stock could still

First-quarter earnings season kicked off last week. With 23% of the U.S. vaccinated, businesses steadily re-opening, and trillions of dollars of monetary fizz getting pumped into the market, it’s no surprise that investor confidence is at an all-time high. Risk-taking is the new normal. And that makes the tug-of-war between Wall Street and Main Street

When I last discussed TPG Pace Beneficial (NYSE:TPGY), I voice some skepticism regarding the special purpose acquisition company. Scheduled to reverse merge with EVBox, an electric vehicle charging solutions provider, the outside fundamentals seemed supportive for TPGY stock. Source: VanderWolf Images / Shutterstock.com After all, everybody was going crazy for electric vehicles, which bode well

Aphria (NASDAQ:APHA) stock is facing a challenging period following its third quarter earnings disappointment.  Source: Shutterstock Aphria announced fiscal year 2021 third quarter financial results on April 12. The news was bad, and as a result share prices plunged. Next, on April 14, Aphria will hold a special meeting for shareholders to approve the Aphria-Tilray

Covering stocks, every once in a while an editor throws you a “Geez, Louise” assignment. That’s how it was with this request to cover C3.ai (NYSE:AI). Still, as one of the most hotly anticipated market debuts, I realized that AI stock charmed investors early on but has since left them bitterly disappointed. Source: Shutterstock When

Among the most beaten-down market sectors during the onset of the novel coronavirus was the cruise-line industry. For a while, it seemed as if the investing community hated Norwegian Cruise Line (NYSE:NCLH). The share-price rout in NCLH stock was absolutely relentless. Source: Roberto Sorin / Shutterstock.com Things certainly have changed during the past year, however. Today,

Investors are getting mixed signals on the state of the economy as we head into spring. On the one hand, investor concerns over inflation, deficit spending and certain Fed decisions continue to cause worry. Some economists fear that a rebound following the pandemic may not be as robust as previously predicted. Still others are betting

It was a manic Monday for Aphria (NASDAQ:APHA) stock, which plunged 14% to $13.92. The reason was simple: the company’s earnings were downright awful. Source: Shutterstock And the bad news spread across the cannabis sector. Stocks like Canopy Growth (NASDAQ:CGC), Cronos Group (NASDAQ:CRON) and Tilray (NASDAQ:TLRY) got hit as well. So what were the numbers

The global chip shortage does not appear to be going anywhere. And it’s interrupted some big rallies in key stocks. The question is whether the hot stocks that have cooled off present buying opportunities. In some cases, they do. After all, the chip shortage should be a relatively short-term phenomenon, even if “short-term” is measured

Coinbase (NASDAQ:COIN) is scheduled to go public on April 14 in a direct listing that will see America’s largest cryptocurrency exchange sell shares directly to investors, foregoing the traditional initial public offering (IPO) process. Source: Primakov / Shutterstock.com As I write this, a reference price has yet to be set. Nasdaq will set this price

BioNTech (NASDAQ:BNTX) stock is sitting on a 48% gain in 2021. And over the last 12 months BNTX stock is up over 168%. The reason is that the company, in partnership with Pfizer (NYSE:PFE), was the first to market with a Covid-19 vaccine. Source: Shutterstock However the significance of the vaccine is about more than

Holding steady at just under $40 per share, can Nio (NYSE:NIO) stock rebound back its past highs? Don’t count on it. Sure, its recent delivery numbers may have been satisfactory. But, with shares in the China-based electric vehicle (EV) company still trading as if recent growth will carry on in the years ahead, shares have